NRXP Annual Shareholders Equity
-$11.73 M
-$19.14 M-258.36%
31 December 2023
Summary:
As of January 23, 2025, NRXP annual stockholders equity is -$11.73 million, with the most recent change of -$19.14 million (-258.36%) on December 31, 2023. During the last 3 years, it has risen by +$32.04 million (+73.19%). NRXP annual shareholders equity is now -156.39% below its all-time high of $20.81 million, reached on December 31, 2021.NRXP Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXP Quarterly Shareholders Equity
-$18.82 M
-$431.00 K-2.34%
30 September 2024
Summary:
As of January 23, 2025, NRXP quarterly stockholders equity is -$18.82 million, with the most recent change of -$431.00 thousand (-2.34%) on September 30, 2024. Over the past year, it has dropped by -$3.75 million (-24.91%). NRXP quarterly shareholders equity is now -159.40% below its all-time high of $31.69 million, reached on March 31, 2022.NRXP Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXP Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -258.4% | -24.9% |
| 3 y3 years | +73.2% | -212.2% |
| 5 y5 years | +73.2% | - |
NRXP Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -156.4% | at low | -159.4% | at low |
| 5 y | 5-year | -156.4% | +73.2% | -159.4% | +57.0% |
| alltime | all time | -156.4% | +73.2% | -159.4% | +57.0% |
NRx Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$18.82 M(+2.3%) |
| June 2024 | - | -$18.39 M(+22.0%) |
| Mar 2024 | - | -$15.07 M(+28.4%) |
| Dec 2023 | -$11.73 M(-258.4%) | -$11.73 M(+88.7%) |
| Sept 2023 | - | -$6.22 M(+121.4%) |
| June 2023 | - | -$2.81 M(+888.7%) |
| Mar 2023 | - | -$284.00 K(-103.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $7.41 M(-64.4%) | $7.41 M(-55.9%) |
| Sept 2022 | - | $16.78 M(-33.8%) |
| June 2022 | - | $25.35 M(-20.0%) |
| Mar 2022 | - | $31.69 M(+52.3%) |
| Dec 2021 | $20.81 M(-147.5%) | $20.81 M(+132.0%) |
| Sept 2021 | - | $8.97 M(-151.4%) |
| June 2021 | - | -$17.44 M(-60.2%) |
| Dec 2020 | -$43.77 M | -$43.77 M |
FAQ
- What is NRx Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual shareholders equity year-on-year change?
- What is NRx Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly shareholders equity year-on-year change?
What is NRx Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of NRXP is -$11.73 M
What is the all time high annual shareholders equity for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual stockholders equity is $20.81 M
What is NRx Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, NRXP annual stockholders equity has changed by -$19.14 M (-258.36%)
What is NRx Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of NRXP is -$18.82 M
What is the all time high quarterly shareholders equity for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly stockholders equity is $31.69 M
What is NRx Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, NRXP quarterly stockholders equity has changed by -$3.75 M (-24.91%)